Fifth Third Bancorp’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.21M | Sell |
67,660
-2,963
| -4% | -$107K | ﹤0.01% | 1210 |
|
|
2026
Q1 | $2.5M | Buy |
70,623
+58,801
| +497% | +$2.39M | ﹤0.01% | 1104 |
|
|
2025
Q4 | $480K | Sell |
11,822
-1,577
| -12% | -$68.6K | ﹤0.01% | 782 |
|
|
2025
Q3 | $630K | Sell |
13,399
-882
| -6% | -$45.7K | ﹤0.01% | 735 |
|
|
2025
Q2 | $744K | Sell |
14,281
-534
| -4% | -$29.3K | ﹤0.01% | 665 |
|
|
2025
Q1 | $895K | Sell |
14,815
-2,881
| -16% | -$186K | ﹤0.01% | 607 |
|
|
2024
Q4 | $1.21M | Sell |
17,696
-7,487
| -30% | -$522K | ﹤0.01% | 551 |
|
|
2024
Q3 | $1.81M | Sell |
25,183
-980
| -4% | -$69.1K | 0.01% | 488 |
|
|
2024
Q2 | $1.81M | Buy |
26,163
+8,112
| +45% | +$592K | 0.01% | 477 |
|
|
2024
Q1 | $1.45M | Buy |
18,051
+672
| +4% | +$59.9K | 0.01% | 523 |
|
|
2023
Q4 | $1.9M | Buy |
17,379
+987
| +6% | +$102K | 0.01% | 457 |
|
|
2023
Q3 | $1.65M | Sell |
16,392
-124
| -0.8% | -$14.2K | 0.01% | 478 |
|
|
2023
Q2 | $2.24M | Sell |
16,516
-3,044
| -16% | -$372K | 0.01% | 434 |
|
|
2023
Q1 | $2.03M | Buy |
19,560
+599
| +3% | +$57.9K | 0.01% | 443 |
|
|
2022
Q4 | $1.68M | Buy |
18,961
+5,207
| +38% | +$432K | 0.01% | 470 |
|
|
2022
Q3 | $1.1M | Buy |
13,754
+13,513
| +5,607% | +$1.27M | 0.01% | 537 |
|
|
2022
Q2 | $23K | Sell |
241
-11
| -4% | -$1.32K | ﹤0.01% | 1673 |
|
|
2022
Q1 | $37K | Hold |
252
| – | – | ﹤0.01% | 1569 |
|
|
2021
Q4 | $36K | Buy |
252
+75
| +42% | +$10.6K | ﹤0.01% | 1651 |
|
|
2021
Q3 | $23K | Buy |
177
+37
| +26% | +$4.84K | ﹤0.01% | 1739 |
|
|
2021
Q2 | $19K | Hold |
140
| – | – | ﹤0.01% | 1802 |
|
|
2021
Q1 | $18K | Buy |
140
+60
| +75% | +$7.22K | ﹤0.01% | 1809 |
|
|
2020
Q4 | $9K | Buy |
80
+65
| +433% | +$6.15K | ﹤0.01% | 1953 |
|
|
2020
Q3 | $1K | Buy |
+15
| New | +$1.22K | ﹤0.01% | 2132 |
|
|
2020
Q1 | – | Sell |
-3,059
| Closed | -$342K | – | 2142 |
|
|
2019
Q4 | $342K | Sell |
3,059
-536
| -15% | -$57.1K | ﹤0.01% | 774 |
|
|
2019
Q3 | $346K | Sell |
3,595
-721
| -17% | -$67.7K | ﹤0.01% | 748 |
|
|
2019
Q2 | $369K | Buy |
4,316
+4,188
| +3,272% | +$344K | ﹤0.01% | 726 |
|
|
2019
Q1 | $11K | Hold |
128
| – | – | ﹤0.01% | 1750 |
|
|
2018
Q4 | $8K | Hold |
128
| – | – | ﹤0.01% | 1829 |
|
|
2018
Q3 | $10K | Hold |
128
| – | – | ﹤0.01% | 1824 |
|
|
2018
Q2 | $9K | Hold |
128
| – | – | ﹤0.01% | 1912 |
|
|
2018
Q1 | $8K | Hold |
128
| – | – | ﹤0.01% | 1943 |
|
|
2017
Q4 | $7K | Hold |
128
| – | – | ﹤0.01% | 1912 |
|
|
2017
Q3 | $7K | Hold |
128
| – | – | ﹤0.01% | 1856 |
|
|
2017
Q2 | $7K | Hold |
128
| – | – | ﹤0.01% | 1807 |
|
|
2017
Q1 | $6K | Buy |
+128
| New | +$5.51K | ﹤0.01% | 1809 |
|
|
2016
Q1 | – | Sell |
-72
| Closed | -$3K | – | 2370 |
|
|
2015
Q4 | $3K | Buy |
72
+1
| +1% | +$43 | ﹤0.01% | 2327 |
|
|
2015
Q3 | $3K | Buy |
71
+21
| +42% | +$1.15K | ﹤0.01% | 2463 |
|
|
2015
Q2 | $3K | Buy |
50
+1
| +2% | +$54 | ﹤0.01% | 2428 |
|
|
2015
Q1 | $2K | Buy |
+49
| New | +$2.4K | ﹤0.01% | 2454 |
|
|
2014
Q4 | – | Sell |
-550
| Closed | -$20K | – | 2380 |
|
|
2014
Q3 | $20K | Hold |
550
| – | – | ﹤0.01% | 1765 |
|
|
2014
Q2 | $24K | Hold |
550
| – | – | ﹤0.01% | 1741 |
|
|
2014
Q1 | $24K | Hold |
550
| – | – | ﹤0.01% | 1714 |
|
|
2013
Q4 | $23K | Hold |
550
| – | – | ﹤0.01% | 1614 |
|
|
2013
Q3 | $19K | Hold |
550
| – | – | ﹤0.01% | 1678 |
|
|
2013
Q2 | $17K | Buy |
+550
| New | +$17.8K | ﹤0.01% | 1638 |
|
Other funds holding CNMD
ICM
Fifth Third Bancorp's CNMD Position: Q2 2026 in Review
Fifth Third Bancorp reduced its CONMED (CNMD) stake by 4.2% in Q2 2026, selling an estimated $107K and leaving 67,660 shares worth $2.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1210.
Fifth Third Bancorp first reported a position in CNMD in Q2 2013 and has held it in 46 quarters since. The position peaked at $2.5M in Q1 2026. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.
- Fifth Third Bancorp held 67,660 shares of CONMED worth $2.21M as of Q2 2026.
- Fifth Third Bancorp sold 2,963 CONMED shares in Q2 2026, an estimated $107K.
- CONMED made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #1210 holding.
- Fifth Third Bancorp first reported a position in CONMED in Q2 2013 and has held it in 46 quarters since.
- Fifth Third Bancorp's CONMED position peaked at $2.5M in Q1 2026.
- 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.
Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.